A comprehensive view of Abbott Laboratories. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GlobalData: FDA approves OTC continuous glucose monitors from Dexcom and Abbott, designed for individuals who don't use insulin; high prediabetes prevalence expected to drive global market of OTC CGMs to reach US$5.1B by 2033

Medical Devices drive strong Q2, prompting full-year guidance raise; new product pipeline boosts health tech innovation and sustains top-tier growth

Abbott Laboratories Champions Veteran Talent and Cardiac Innovation with Strategic Brand Management and TriClip System

Abbott reports Q2 2024 sales of $10.4 billion with 4% growth; Adjusted diluted EPS at $1.14, and full-year EPS guidance raised to $3.30-$3.40 GAAP and $4.61-$4.71 adjusted

Abbott Laboratories champions specialized nutrition with EleCare formula mitigating severe food allergies; company emphasizes strong leadership to drive innovation in healthcare industry

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count